Anesthesia

Latest Issue of OR Manager
April 2024
Home Anesthesia

Study shows serious downside, risks to postop opioid prescription at discharge

Editor's Note This cohort study, published by the British Journal of Anesthesia in September 2023, finds that surgical patients who are discharged with prescribed opioids have higher risks of hospital readmission and mortality.  The study looked at data from a territory-wide retrospective cohort of patients in Hong Kong who underwent…

Read More

By: Brita Belli
September 25, 2023
Share

Anesthesiology research pipeline needs boost

Editor's Note Anesthesiology needs to bolster initiatives to improve the size and diversity of research scientists in its pipeline, according to a new study by the Anesthesia Research Council (ARC), titled "The Anesthesiology Physician-Scientist Pipeline: Current Status and Recommendations for Future Growth" and published in the October 2023 Anesthesia &…

Read More

By: Brita Belli
September 25, 2023
Share

Anesthesia & Analgesia journal devotes October issue to DEI

Editor's Note Citing the pervasive connections between healthcare disparities and race and gender, Anesthesia & Analgesia, the oldest publication dedicated exclusively to the specialty of anesthesiology, is devoting its October 2023 issue to diversity, equity, and inclusion (DEI) topics in the field. The issue lays out a number of practical…

Read More

By: Brita Belli
September 22, 2023
Share

OR Manager Conference kicks off, celebrates 36 years of excellence

Editor's Note After a Sunday full of pre-conference workshops and an exciting off-site tour, the OR Manager Conference opens today! Since the early days of the conference, OR Manager has expanded and improved every year by diversifying education offerings, and this year, we are celebrating 36 years of bringing leaders…

Read More

By: Tarsilla Moura
September 15, 2023
Share

Sponsored Message

The Joint Commission: World Patient Safety Day is September 17

Editor's Note On September 17, World Patient Safety Day, The Joint Commission is partnering with the World Health Organization in recognizing the shared commitment to safe, equitable, high quality care for all and asks all accredited organizations and partners to join in the recognition. This year’s theme, “Engaging patients for…

Read More

By: Judy Mathias
September 14, 2023
Share

ACS addresses opioid prescription misuse with new QI project

Editor's Note The American College of Surgeons (ACS), on September 12, announced a new quality improvement (QI) project that will evaluate the most effective ways to help patients safely manage postoperative pain and reduce the risk of opioid dependence. The project will be conducted in collaboration with Health Care Service…

Read More

By: Judy Mathias
September 13, 2023
Share

Sponsored Message

FDA: Class I recall of Mallinckrodt One-Way Valve, 22F x 22M

Editor's Note The Food and Drug Administration (FDA), on September 12, identified the recall by Mallinckrodt Manufacturing of its One-Way Valve, 22F x 22M, as Class I, the most serious. The recall was issued because the devices are not opening properly, which prevents or reduces the flow of ventilated air…

Read More

By: Judy Mathias
September 13, 2023
Share

New CMS rule focuses on postop opioids in outpatient settings

Editor's Note The Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act, which is set to take effect in 2025, will set up a separate Centers for Medicare and Medicaid Services (CMS) payment for certain nonopioid pain management techniques in outpatient and ambulatory surgery center (ASC) settings, the September 12 Becker’s…

Read More

By: Judy Mathias
September 12, 2023
Share

COVID-19 hospitalizations, deaths increasing

Editor's Note The COVID-19 hospital admission rate in the US rose some 16% to more than 17,400 for the week ending August 26, and deaths increased by nearly 18% from the prior week, the September 7 New York Times reports. This marks the seventh consecutive week of increases. The Omicron…

Read More

By: Judy Mathias
September 11, 2023
Share

FDA: Class I recall of Cardiosave Hybrid, Rescue IABPs

Editor's Note The Food and Drug Administration (FDA), on August 31, identified the recall by Getinge/Maquet/Datasocpe of its Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) as Class I, the most serious. The FDA posted four recalls for four separate reasons: Because they may overheat when the device’s internal temperature…

Read More

By: Judy Mathias
September 5, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat